Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere. Founded by a team of highly-experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
As a global operation since inception, Creso’s experienced leadership and geographical agility has enabled tactical expansion in a diverse range of markets:
First to import medicinal cannabis into Australia
First launches of innovative products into Switzerland for humans and animals
Launch of anibidiol®: the first hemp CBD based complementary feed in animal health in partnership with Virbac Switzerland (Global Animal Health company)
Launch of cannaQIX®: the first CBD nutraceutical in human health in partnership with Doetsch Grether AG Switzerland (Swiss OTC Pharma)
Formally entered the Canadian market by acquiring Mernova, a Nova Scotia based Medical Cannabis growing operation
Pioneered new opportunities for cannabis and hemp derived ingredients in the lifestyle space, specifically chocolates and alcoholic and non-alcoholic beverages